Form 10-K
DEF 14A
DEF 14A
Form 10-K
Teva Investor Relations on the App Store
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
Form 10-K
SEC Filing Fee Exhibit, Payment and Related Changes | Goodwin - JDSupra
Teva Pharmaceutical Industries SEC Filings & 10K Form (NYSE:TEVA)
DEF 14A
DEF 14A
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire
SEC Filing | Adamis Pharmaceuticals Corporation
Abrams Capital Management, L.p. ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
ARK Investment Management LLC reports 1.57% decrease in ownership of TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
DEF 14A
DEF 14A
DEF 14A
DEF 14A
BlackRock Investment Management, LLC ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
DEF 14A
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
